EDITORIAL: Antigenic Response to Ct-P13 and Infliximab Originator in Ibd Shows Similar Epitope Recognition-Evidence from Basic Science Supports Safe Switching to Biosimilars. Authors' Reply

AuthID
 P-00P-E38
5
Author(s)
Danese, S
·
Lakatos, PL
·
Ben Horin, S
Document Type
Editorial Material
Year published
2018
Published
in ALIMENTARY PHARMACOLOGY & THERAPEUTICS, ISSN: 0269-2813
Volume: 48, Issue: 5, Pages: 575-576 (2)
Indexing
Wos®
Scopus®
Crossref®
Google Scholar®
Publication Identifiers
Scopus: 2-s2.0-85051276943
Wos: WOS:000441233600009
Source Identifiers
ISSN: 0269-2813
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service